PARLODEL Drug Patent Profile

✉ Email this page to a colleague

When do Parlodel patents expire, and when can generic versions of Parlodel launch?

Parlodel is a drug marketed by Ss Pharma and is included in one NDA.

The generic ingredient in PARLODEL is bromocriptine mesylate. There are nine drug master file entries for this compound. Eight suppliers are listed for this compound. Additional details are available on the bromocriptine mesylate profile page.

DrugPatentWatch^® Litigation and Generic Entry Outlook for Parlodel

A generic version of PARLODEL was approved as bromocriptine mesylate by SANDOZ on January 13^th, 1998.

Try a Trial

Summary for PARLODEL

US Patents:	0
Applicants:	1
NDAs:	1
Finished Product Suppliers / Packagers:	1
Raw Ingredient (Bulk) Api Vendors:	54
Clinical Trials:	10
Patent Applications:	3,142
Formulation / Manufacturing:	see details
Drug Prices:	Drug price information for PARLODEL
What excipients (inactive ingredients) are in PARLODEL?	PARLODEL excipients list
DailyMed Link:	PARLODEL at DailyMed

Drug patent expirations by year for PARLODEL

Recent Clinical Trials for PARLODEL

Identify potential brand extensions & 505(b)(2) entrants

Sponsor	Phase
National Heart, Lung, and Blood Institute (NHLBI)	Phase 4
Dennis McNamara	Phase 4
University of California, San Diego	Early Phase 1

See all PARLODEL clinical trials

Pharmacology for PARLODEL

Drug Class	Ergot Derivative

Anatomical Therapeutic Chemical (ATC) Classes for PARLODEL

G02CB	Prolactine inhibitors
G02C	OTHER GYNECOLOGICALS
G02	OTHER GYNECOLOGICALS
G	Genito-urinary system and sex hormones

N04BC	Dopamine agonists
N04B	DOPAMINERGIC AGENTS
N04	ANTI-PARKINSON DRUGS
N	Nervous system

US Patents and Regulatory Information for PARLODEL

+ Get email alerts for changes to this table

Glossary

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	TE	Type	RLD	RS	Patent No.	Patent Expiration	Product	Substance	Delist Req.	Exclusivity Expiration
Ss Pharma	PARLODEL	bromocriptine mesylate	CAPSULE;ORAL	017962-002	Mar 1, 1982	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
Ss Pharma	PARLODEL	bromocriptine mesylate	TABLET;ORAL	017962-001	Approved Prior to Jan 1, 1982	AB	RX	Yes	No	⤷ Try a Trial	⤷ Try a Trial				⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>TE	>Type	>RLD	>RS	>Patent No.	>Patent Expiration	>Product	>Substance	>Delist Req.	>Exclusivity Expiration

Expired US Patents for PARLODEL

Subscribe to access the full database, or Try a Trial
Applicant	Tradename	Generic Name	Dosage	NDA	Approval Date	Patent No.	Patent Expiration
Ss Pharma	PARLODEL	bromocriptine mesylate	TABLET;ORAL	017962-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Ss Pharma	PARLODEL	bromocriptine mesylate	TABLET;ORAL	017962-001	Approved Prior to Jan 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Ss Pharma	PARLODEL	bromocriptine mesylate	CAPSULE;ORAL	017962-002	Mar 1, 1982	⤷ Try a Trial	⤷ Try a Trial
Ss Pharma	PARLODEL	bromocriptine mesylate	CAPSULE;ORAL	017962-002	Mar 1, 1982	⤷ Try a Trial	⤷ Try a Trial
>Applicant	>Tradename	>Generic Name	>Dosage	>NDA	>Approval Date	>Patent No.	>Patent Expiration

International Patents for PARLODEL

See the table below for patents covering PARLODEL around the world.

Subscribe to access the full database, or Try a Trial
Country	Patent Number	Title	Estimated Expiration
Denmark	124884		⤷ Try a Trial
Yugoslavia	133669		⤷ Try a Trial
Sweden	341854		⤷ Try a Trial
Yugoslavia	33970		⤷ Try a Trial
>Country	>Patent Number	>Title	>Estimated Expiration

Summary for PARLODEL

Recent Clinical Trials for PARLODEL

Pharmacology for PARLODEL

Anatomical Therapeutic Chemical (ATC) Classes for PARLODEL

Make Better Decisions: Try a trial or see plans & pricing